Vietnamese expert joins first global tuberculosis task force
Dr Nguyen Viet Nhung, Director of the Central Pulmonology Hospital, is one of the 19 members of the first task force on global tuberculosis research founded by the World Health Organisation (WHO).
Dr Nguyen Viet Nhung (fifth from right) and other members of WHO’s task force on global tuberculosis research at their first meeting in Switzerland. (Photo: VNA)
Hanoi (VNA) - Dr Nguyen Viet Nhung, Director of the Central Pulmonology Hospital,is one of the 19 members of the first task force on global tuberculosisresearch founded by the World Health Organisation (WHO).
Thefirst meeting of the team was held on December 9 at the WHO headquarters inGeneva, Switzerland.
Accordingto the organisation, Vietnam is one of the three countries whose research plansfor tuberculosis treatment are highly acclaimed.
Vietnam’ssuccess in tuberculosis prevention has been recognised nationwide andinternationally over the years. Each year, the country detects and providestreatment for 100,000 people with tuberculosis, with a cure rate of over 90 percent for new cases.
Mostof the new technologies applied in tuberculosis treatment appeared to beeffective. Some 6,000 patients who had drug-resistant tuberculosis wereadmitted for treatment in recent years.
VICTORY,the country’s specialised tuberculosis research co-operation centre, hasdeveloped a wide research network for tuberculosis and lung diseases.
Theresearch process provided essential database for the planning of large-scalepolicies, such as the National Tuberculosis Programme until 2020, with a visionto 2030.
Atthe meeting, Dr Nhung spoke about the importance of research for the programmeand the experiences gained from it.
InJune, he was voted as the first Vietnamese to join the Strategic and TechnicalAdvisory Group for Tuberculosis, which is the highest operating and strategicplanning mechanism for tuberculosis control of WHO.-VNA
Vietnam and Fiji have been elected as representatives for the Western Pacific region in the World Health Assembly’s Executive Board for a three-year tenure from May 2016 – May 2019.
A Vietnamese representative was elected to the World Health Organisation Strategic and Technical Advisory Group for Tuberculosis (STAG-TB) for the first time.
Vietnam earned another four awards in the latest round of the Partnerships for Enhanced Engagement in Research (PEER), a US-funded programme to fund scientific research in developing countries.
Despite storm-related disruptions and flight delays, the organs were successfully transported via a combination of air and ground travel. All patients are currently stable and recovering well.
The patient, Tieu Viet But, born in 1970 and residing in Binh Tri commune, Binh Son district, the central province of Quang Ngai, was working aboard fishing vessel Qng – 95657TS when the incident occurred at 7:00 am.
All drugs entering hospitals must have a clear origin, so counterfeit drugs are only in the market, not in hospital, affirmed Minister of Health Dao Hong Lan.
To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
Health experts called for collective disease prevention and integrated solutions to achieve zero dengue deaths in the country at an online talk show on June 14.
The PM called for closer, broader, and more effective cooperation with Vietnamese partners, guided by the principles of mutual benefit, joint efforts, shared outcomes, and common development, including promoting stronger public-private partnerships and collaboration with businesses.
Renowned for its expertise in complex surgeries, the hospital has attracted foreign patients seeking treatment for conditions such as kidney and urinary tract stones, urological and gastrointestinal cancers, and male reproductive disorders. Most procedures are performed using advanced techniques, including laparoscopy and robotic surgery. T
Leading Vietnamese companies specialising in respiratory and dermatological treatments, traditional medicine, immune support supplements, and functional foods will have an opportunity to connect with international distributors and secure export deals.
The project aimed to enable early detection and reduce the risk of dangerous complications, targeting patients with chronic diabetes, cardiovascular conditions and metabolic disorders.
A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
All eligible patients will receive surgical interventions and post-operative care in accordance with Vietnamese medical standards and global care protocols.
Medical screenings and surgical interventions for children with disabilities are being carried out at health centers across Dien Bien. So far this year, 242 children have been identified for diagnosis, treatment, surgery, and the provision of assistive devices.
The Red Journey has become the country’s largest and most effective blood donation campaign, leaving a strong impression on the national voluntary blood donation movement.
This case marks the ninth fetal cardiac intervention conducted in HCM City, and it was considered the most technically demanding to date due to the fetus’s extremely early gestational age and the severity of the condition as diagnosed with aortic atresia.
The groundbreaking ceremony took place one day after the VNVC Vaccine JS Company and Sanofi Group exchanged cooperation documents on vaccine production technology transfer under the witness of State President Luong Cuong and French President Emmanuel Macron.
Vietnam’s traditional medicine took centre stage at the International Congress Biopharm Nonclinical Development, BioNCiD 2025, held on May 25-26 in the Cuban city of Varadero, amid growing global interest in sustainable healthcare solutions.
Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
Despite the ongoing global circulation and unpredictable developments of SARS-CoV-2, the World Health Organisation (WHO) hasn’t issued new warnings about COVID-19, said the Ministry of Health.